checkAd
    Startseite > Aktien > Aridis Pharmaceuticals > Nachrichten
    Aridis Pharmaceuticals Aktie
    0,0600
     
    USD
    +1,69 %
    +0,0010 USD
    Letzter Kurs 11.05.24 Nasdaq OTC
    ISIN: US0403341045 · WKN: A2N38H · SYM: ARDS · USA

    Neueste Nachrichten

    Aridis Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders until January 12, 2024
    15.12.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Pharmaceuticals Announces Third Quarter 2023 Financial Results and Business Update
    03.11.23 · globenewswire · Aridis Pharmaceuticals
    Reviva Pharmaceuticals Holdings, Inc. and Aridis Pharmaceuticals, Inc. Interviews to Air on the RedChip Money Report(R) on Bloomberg TV
    22.09.23 · Accesswire · Aridis Pharmaceuticals
    Aridis Pharmaceuticals Announces $2 Million Offering
    02.08.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301
    17.07.23 · globenewswire · Aridis Pharmaceuticals
    Aridis’ AR-301 Monoclonal Antibody is Among the First Biologics to Receive FDA’s Qualified Infectious Diseases Product (QIDP) Designation
    12.07.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Pharmaceuticals' AR-301 Eligible for Consideration under FDA’s Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD)
    20.06.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Pharmaceuticals Announces First Quarter 2023 Financial Results and Business Update
    08.06.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design
    31.05.23 · globenewswire · Aridis Pharmaceuticals
    Aridis Pharmaceuticals Receives Nasdaq Notice on Late Filing of its Form 10-Q
    25.05.23 · globenewswire · Aridis Pharmaceuticals